Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:2753-2759
Published online before print May 13, 2002, doi: 10.1161/01.CIR.0000018443.44005.D8
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/23/2753    most recent
01.CIR.0000018443.44005.D8v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bettoni, M.
Right arrow Articles by Zimmermann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bettoni, M.
Right arrow Articles by Zimmermann, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation
Related Collections
Right arrow Electrocardiology
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Autonomic, reflex, and neurohumoral control of circulation

(Circulation. 2002;105:2753.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Autonomic Tone Variations Before the Onset of Paroxysmal Atrial Fibrillation

Marco Bettoni, MD; Marc Zimmermann, MD, FESC

From the Cardiology Unit, Cardiovascular Department, Hôpital de La Tour, Geneva, Switzerland. Member of the RETAC (Réseau Européen pour le Traitment des Arythmies Cardiaques).

Correspondence to Marc Zimmermann, MD, Cardiovascular Department, Hôpital de La Tour, 1 avenue JD Maillard, CH-1217 Meyrin (Geneva), Switzerland. E-mail zimmermann.family{at}bluewin.ch


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Background Mechanisms favoring the occurrence of paroxysmal atrial fibrillation (PAF) are complex and poorly defined. This study was designed to analyze dynamic changes in autonomic tone preceding the onset of PAF in a large group of patients.

Methods and Results Holter tapes from 77 unselected consecutive patients (63 men and 14 women aged 58±12 years) with PAF were analyzed. A total of 147 episodes of sustained AF (>30 minutes) were recorded and submitted to time-domain and frequency-domain heart rate variability analyses; 6 periods were studied using repeated measures ANOVA: the 24-hour period, the hour preceding PAF, and the 20 minutes before PAF divided into four 5-minute periods. In the time-domain analyses, a linear decrease in mean RR interval from 925±16 to 906±16 ms (P<0.0002) was observed before the onset of PAF, together with a significant increase in the standard deviation of NN intervals from 65±4 to 70±4 ms (P<0.02). In the frequency-domain analyses, a significant increase in high-frequency (HF, HF-NU) components was observed before PAF (P<0.001 and P<0.0001, respectively), together with a progressive decrease in low-frequency components (LF, LF-NU) (P<0.0001 and P<0.004, respectively). The low/high frequency ratio showed a linear increase until 10 minutes before PAF, followed by a sharp decrease immediately before PAF, suggesting a primary increase in adrenergic tone followed by a marked modulation toward vagal predominance. No difference was observed in these heart rate variability changes between patients with "lone" PAF and patients with structural heart disease.

Conclusions The occurrence of PAF greatly depends on variations of the autonomic tone, with a primary increase in adrenergic tone followed by an abrupt shift toward vagal predominance.


Key Words: fibrillation • heart rate • nervous system, autonomic


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Paroxysmal atrial fibrillation (PAF) is one of the most common arrhythmias in patients with and without structural heart disease.1,2 Atrial fibrillation (AF) is thought to be due to multiple wavelet reentry,3 and it has been shown recently that the trigger for PAF is often related to arrhythmogenic foci located at or near the orifice of the pulmonary veins, which can be successfully eliminated by radiofrequency catheter ablation.47 Moreover, the role of the autonomic nervous system in the genesis and/or in the maintenance of AF has been clinically recognized for many years.8,9 Autonomic fluctuations before the onset of PAF have been recognized in several studies1012 but with conflicting results: a shift toward an increase in sympathetic tone or toward a loss of vagal tone has been observed before postoperative PAF,13 before the onset of atrial flutter,14 before PAF occurring during sleep,15 and in some patients with "lone" AF,16 whereas a shift toward vagal predominance was observed in young patients with lone AF and nocturnal episodes of PAF.17 Recently, observations made in patients with focal ectopy originating from the pulmonary veins have suggested a primary increase in adrenergic drive followed by marked modulation toward vagal predominance before the onset of PAF.12 To further improve our knowledge on the role of the autonomic nervous system in the genesis of PAF, we conducted a study designed to analyze dynamic changes in autonomic tone before the onset of sustained atrial arrhythmias in a large group of unselected patients with or without structural heart disease who presented with recurrent episodes of PAF.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Twenty-four-hour Holter tape recordings from 77 consecutive, unselected patients (63 men and 14 women aged 58±12 years) with PAF were prospectively collected between 1996 and 2000 and then analyzed. The clinical characteristics of the study population are summarized in Table 1. The presence and type of structural heart disease was assessed on the basis of medical history, clinical examination, 12-lead resting ECG, exercise stress testing, echocardiography and, in selected cases, coronary angiography. The diagnosis of lone AF was made in the absence of any structural heart disease in patients <60 years of age. In 15 patients, an electrophysiological study was performed together with radiofrequency catheter ablation of one or more arrhythmogenic foci (pulmonary vein foci in 14 patients; right atrial focus in 1 patient; immediate success in all; early recurrence in 7 of the 14).


View this table:
[in this window]
[in a new window]
 
Table 1. Clinical Characteristics of the Study Population (n=77)

Holter tapes were eligible for analysis if the following criteria were met: (1) normal sinus rhythm during at least 70% of the recording period, (2) occurrence of one or more episode(s) of sustained (>30 minutes) AF, (3) presence of at least 1 hour of sinus rhythm before the onset of PAF, and (4) the presence of >80% of N-N intervals during the period of recording. For clinical and ethical reasons (rapid ventricular response during AF), it was not possible to withdraw all antiarrhythmic drugs during Holter recording in selected patients. Therefore, 9 patients (12%) were taking amiodarone, 18 (23%) were on ß-blockers, and 10 (13%) were taking digoxin at the time of recording.

All 24-hour ambulatory recordings were performed using a 2-channel bipolar recorder (Recorder 8500, Marquette Electronics Inc) and analyzed using the MARS 8000 Workstation and software (Marquette Electronics Inc). Only high-quality recordings were considered for analysis. As described previously, 12 all tapes were converted to a digitized format and reviewed by an experienced operator. All episodes of sustained atrial arrhythmias were manually identified, labeled, and printed out on paper (30 seconds per line at 25 mm/s). Ventricular and supraventricular ectopic beats, as well as the preceding and the following RR interval of each ectopic beat, were excluded from heart rate variability (HRV) analysis.

HRV was used as indicator of autonomic activity in accordance with guidelines for standardization.18 Six time periods were selected for HRV: the 24-hour period of recording, the hour preceding the onset of sustained AF, and the 20 minutes preceding the onset of sustained AF, which were divided into four 5-minute periods (15 to 20 min, 10 to 15 min, 5 to 10 min, and 0 to 5 min preceding the onset of sustained AF). The following time-domain HRV parameters were analyzed: mean RR interval (mean NN interval, in ms), the standard deviation of NN intervals (SDNN; in ms), the standard deviation of 5-minute means of NN intervals (SDANN; in ms), the root-mean square of differences between successive NN intervals (in ms), and the proportion of adjacent NN intervals differing by >50 ms (%). HRV in the frequency domain (fast Fourier transform) was analyzed over the same 5-minute periods, and the following parameters were calculated: very-low-frequency components (VLF; <0.04 Hz), low-frequency components (LF; from 0.04 to 0.15 Hz), high-frequency components (HF; from 0.15 to 0.40 Hz), and the ratio of LF/HF. The LF and HF oscillatory components were analyzed both in absolute (ms2) and normalized units obtained using the following formula: Down


Power indicates the power of LF or HF.18 Moreover, the power of each frequency band was logarithmically transformed to avoid the undue influence of extreme values; this was expressed in ln (ms2).

Statistical Analysis
Data are presented as mean±SEM for HRV parameters and as mean±SD for clinical and Holter data. Comparisons of data obtained at different time intervals were performed using repeated measures ANOVA. An unpaired Student’s t test was used to compare the results of HRV parameters between different groups (patients with versus those without structural heart disease; nocturnal PAF episodes versus diurnal PAF episodes; patients with versus patients without ß-blockers). P<0.05 was used as a cut-off for statistical significance.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Clinical Characteristics
PAF had been present for 3.3±2.5 years. History suggested an adrenergic dependence (AF provoked by exercise or stressful situations) in 10% of the cases, and vagally-mediated AF (AF occurring during sleep) in 24% of the cases. However, in most patients (51 of the 77; 66%) no clear-cut precipitating factor before AF onset could be deducted from the history (Table 1).

Holter Data
Among the 77 patients, a total of 147 episodes of sustained AF fulfilled the inclusion criteria and were submitted to analysis. The mean sinus rate was 78±15 bpm, (mean maximal sinus rate, 173±39 bpm; mean minimal sinus rate, 47±12 bpm), and the mean number of atrial premature beats per patient during sinus rhythm was 1484±2384. Nocturnal occurrence of PAF was observed in 95 of 147 episodes (65%) at the time of recording. Before the onset of PAF, a long-short sequence was observed in 98 of 147 episodes (67%), both with (73 of 147 episodes) and without (25 of 147 episodes) atrial bigeminy (mean duration, 6±5 s). Acceleration of sinus rate was present in only 5 of 147 episodes (3%).

Time-Domain HRV Parameters
HRV parameters can be found in Table 2. A significant and linear change in the mean RR interval was observed over the 20 minutes preceding the onset of sustained episodes of PAF (from 925±16 to 906±16 ms; P<0.0002; Figure 1A). The mean RR interval during the 5 minutes preceding the onset of AF was not significantly different from the mean RR interval of the 24-hour period of recording (906±16 versus 897±13 ms; P=0.39) or from the mean RR interval of the hour preceding AF (906±16 versus 916±15 ms; P=0.31). The mean SDNN value increased significantly over the 20 minutes preceding the onset of AF (from 65±4 to 70±4 ms; P<0.05), but the SDNN value of the 5 minutes preceding AF was significantly lower compared with the SDNN value of the hour preceding AF (70±4 versus 80±3 ms; P<0.001) or compared with the SDNN value of the 24-hour period of recording (70±4 versus 120±4 ms; P<0.001). The mean SDANN did not show any significant change before AF, but a trend toward a progressive increase was observed between the 20 minutes and the 5 minutes preceding AF (from 27±2 to 31±2 ms; P=0.09). However, the mean SDANN value was significantly lower during the 5 minutes preceding AF compared with the SDANN value of the hour preceding AF (32±3 versus 51±3 ms; P<0.0001) or compared with the SDANN value of the 24-hour period of recording (32±3 versus 99±3 ms; P<0.0001). No significant changes were observed for the root-mean square of differences or for the proportion of adjacent NN intervals differing by >50 ms during the 20 minutes preceding the onset of AF.


View this table:
[in this window]
[in a new window]
 
Table 2. Changes in HRV Parameters Before the Onset of PAF



View larger version (43K):
[in this window]
[in a new window]
 
Figure 1. Dynamic changes in RR intervals (A), HF components (B), LF components (C), and LF/HF ratio (D) before onset of AF. See text for details. Data are expressed as mean±SEM.

Frequency-Domain HRV Parameters
A significant increase in HF values (P<0.001) was observed before the onset of sustained AF (Figure 1B). This increase was linear, with the highest value of HF observed during the 10 to 5 minutes preceding the onset of AF. Comparable results were observed for normalized HF values or when HF values were logarithmically transformed (Table 2). An initial linear increase in LF values was observed before the onset of AF, but it was present only until 15 minutes before the onset of AF and was then followed by a marked decrease (from 1315±309 to 935±124 ms; P<0.0001; Table 2 and Figure 1C). Comparable results were observed for normalized LF values or when LF values were logarithmically transformed. No significant change in the LF/HF ratio was observed (P=0.11), but there was a progressive increase in the LF/HF ratio until 10 minutes before AF, followed by a sharp decrease during the 5 minutes preceding the onset of AF (from 4.9±0.3 to 3.9±0.3; Figure 1D). No significant changes were observed in VLF values before the onset of sustained episodes of PAF.

Comparison Between Patients With Lone AF and Patients With Structural Heart Disease
Except for the mean RR interval during the 24-hour period of recording (significantly shorter in patients with structural heart disease: 824±30 ms versus 912±15 ms; P=0.01), the various HRV parameters were not significantly different between patients with lone AF and those with structural heart disease (Table 3). The autonomic variations showed the same pattern in both groups, with a significant increase in LF followed by an increase in HF before the onset of PAF.


View this table:
[in this window]
[in a new window]
 
Table 3. Comparison of HRV Parameters Between Patients With Lone PAF (n=62) and Patients With PAF Associated With Structural Heart Disease (n=15)

Comparison Between Nocturnal and Diurnal Episodes of PAF
HF values were significantly higher before nocturnal episodes of PAF, and the LF/HF ratio was significantly lower before nocturnal episodes, thus confirming a vagal predominance at night. An increase in HF values was observed before AF onset before both diurnal and nocturnal episodes, but this increase reached significance only in the nocturnal group (P<0.0001 for HF in the nocturnal group; P=0.08 for HF in the diurnal group). No significant variation was observed for LF values in the diurnal group, whereas a significant increase in LF values was observed in the nocturnal group (P<0.0001) during the 20 minutes preceding AF onset.

Comparison Between Patients With and Without ß-Blockers
As expected, the mean RR interval was significantly longer in patients treated with ß-blockers, with higher values for SDNN and SDANN (Table 4). In the frequency-domain, HRV parameters were comparable between the 2 groups except for HF (normalized units) values, which were significantly lower in patients treated with ß-blockers. The dynamic pattern of frequency-domain HRV parameters was comparable in patients with and without ß-blockers (Tables 5 and 6), with a primary increase in LF until 15 minutes before AF followed by a sharp decrease immediately before AF onset (Figure 2).


View this table:
[in this window]
[in a new window]
 
Table 4. HRV Parameters in Patients Taking and Not Taking ß-Blockers


View this table:
[in this window]
[in a new window]
 
Table 5. Changes in HRV Parameters Before the Onset of PAF in Patients Not Taking ß-Blockers



View larger version (43K):
[in this window]
[in a new window]
 
Figure 2. Dynamic changes in HF components, LF components, and LF/HF ratio before onset of PAF in patients taking ß-blockers (A, B, and C) and those not taking ß-blockers (D, E, and F). See text for details. Data are expressed as mean±SEM.


View this table:
[in this window]
[in a new window]
 
Table 6. Changes in HRV Parameters Before the Onset of PAF in Patients Taking ß-Blockers


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowConclusions
down arrowReferences
 
This study demonstrates significant changes in HRV parameters before the onset of PAF in patients with and without structural heart disease. The present data suggest a primary increase in adrenergic drive occurring over at least 20 minutes before the onset of PAF followed by a shift in the autonomic tone toward more vagal predominance immediately before the onset of PAF.

The role of autonomic tone in the genesis of atrial arrhythmias has been clinically recognized for many years,8,19 but characterization and quantification of these autonomic changes are extremely complex and are therefore difficult to define. The main tool in clinical cardiology to evaluate autonomic nervous system activity is the analysis of HRV parameters on continuous ECG recordings.18 Among them, frequency-domain HRV parameters obtained by spectral analysis are considered the most useful to document changes in the sympathetic/parasympathetic balance. The HF components are thought to reflect primarily vagal tone, whereas LF components are more complex but probably reflect sympathetic activity or the sympathovagal balance.18 Several studies have been conducted to analyze variations of autonomic tone before the occurrence of atrial arrhythmias, but conflicting results have been reported.1317

A shift toward vagal predominance was observed essentially in patients with PAF and a structurally normal heart,10,16 especially in young patients with nocturnal AF17 or in patients with PAF triggered by pulmonary vein foci.12 Several observations suggest that most patients with idiopathic PAF are clearly vagally dependent, with a heightened susceptibility to vasovagal cardiovascular response, whereas most patients with organic PAF are more sympathetic dependent.17,2022 Vagal stimulation has been shown to shorten the atrial refractory period23 and to facilitate reentry,24 and this effect has been used to induce or maintain AF in experimental models.25 Recently, Schauerte and coworkers26 showed that transvascular atrial parasympathetic nerve system modification by radiofrequency catheter ablation could abolish vagally-mediated AF, thus proving the major role played by the parasympathetic tone on the induction and/or maintenance of AF. However, some authors have suggested an increase in sympathetic tone (or a loss of vagal tone) before the onset of PAF in certain subsets of patients.10,13,14,27

In the present study, spectral analysis of HRV showed a complex interaction, with an increase in adrenergic tone and an increase in vagal tone: the increase in HF components before the onset of PAF suggests a vagal rather than an adrenergic predominance immediately before the onset of PAF, whereas the increase in LF components occurring 20 to 5 minutes before the onset of PAF suggests an increase in adrenergic tone preceding the increase in parasympathetic tone. The pattern observed for the LF/HF ratio (Figure 1D) is compatible with these dynamic changes in autonomic tone. The complex fluctuations of autonomic tone occurring before the onset of PAF are underlined by the results of time-domain HRV analysis: a linear decrease in RR interval values was observed before the onset of PAF, suggesting an increase in sympathetic tone together with an increase in SDNN, a parameter predominantly reflecting vagal modulation. Others have reported similar results in patients with lone AF16,17,22 and in patients with "focal" AF.12

Some studies have suggested that in patients with structural heart disease, there is no change in vagal activity before the onset of AF.11,16 In the present study, we found no statistical difference in HRV parameters between patients with lone AF and AF patients with structural heart disease: in both groups, the same fluctuations of autonomic tone were observed, suggesting that vagal influences are not only preponderant in patients with normal hearts. The only parameter significantly different between these 2 groups was the mean RR interval over the 24-hour period of recording, indicating a higher basic sinus rate in patients with structural heart disease. Finally, as pointed out by others,3 long-short sequences were frequently observed before the onset of AF (67%), with or without atrial bigeminy of usually short duration (50% of the cases).

Study Limitations
HRV is only an indirect measure of cardiac autonomic tone and therefore interpretation concerning the exact mechanism underlying the present observation should be cautious. Analysis of time-domain HRV parameters is less accurate in short-term recordings, and therefore data concerning SDNN (estimate of overall HRV) and SDANN (estimate of long-term components of HRV) should be interpreted with caution.18 Results of this study may not be applicable to all patients with PAF because the number of patients with structural heart disease included in this study was relatively small. However, the number of AF episodes is large enough to draw conclusions about fluctuations in autonomic tone before PAF. Only sustained (>30 minutes) episodes of AF were analyzed, and no conclusion can be made for shorter episodes of AF. For technical reasons, patients with numerous premature beats during the period of recording had to be excluded, and our conclusions may not be applicable to this subset of AF patients. Many patients were on medication during Holter recording, which may have influenced the measures of HRV. However, results were comparable in patients taking and those not taking ß-blockers, and no change was observed when patients on digoxin or amiodarone were excluded from analysis, suggesting that medication per se had no major effect on our observations.


*    Conclusions
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*Conclusions
down arrowReferences
 
The present study suggests that PAF episodes are preceded by fluctuations in autonomic tone, with a primary increase in adrenergic drive followed by a marked modulation toward vagal predominance. Such variations are observed in both patients with structural heart disease and those with lone AF, and they do not seem to be influenced by ß-blockers. These data provide important information about the complex role of the autonomic nervous system as a modulating factor for the initiation and/or maintenance of AF.

Received February 21, 2001; revision received March 22, 2002; accepted April 3, 2002.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowConclusions
*References
 
1. Fleinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995; 155: 469–478.[Abstract/Free Full Text]

2. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med. 1987; 317: 669–674.[Abstract]

3. Moe GK, Rheinboldt WC, Abildskov JA. A computer model of atrial fibrillation. Am Heart J. 1964; 67: 200–220.[CrossRef][Medline] [Order article via Infotrieve]

4. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998; 339: 659–666.[Abstract/Free Full Text]

5. Jaïs P, Haïssaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997; 95: 572–576.[Abstract/Free Full Text]

6. Hwang C, Karagueuzian HS, Chen PS. Idiopathic paroxysmal atrial fibrillation induced by a focal discharge mechanism in the left superior pulmonary vein: possible roles of the ligament of Marshall. J Cardiovasc Electrophysiol. 1999; 10: 636–648.[Medline] [Order article via Infotrieve]

7. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999; 100: 1879–1886.[Abstract/Free Full Text]

8. Coumel P, Attuel P, Leclercq JF, et al. Arythmies auriculaires d’origine vagale ou catécholergique. Arch Mal Coeur. 1982; 4: 373–381.

9. Coumel P. Role of the autonomic nervous system in paroxysmal atrial fibrillation. Clin Cardiol. 1990; 13: 209–212.[Medline] [Order article via Infotrieve]

10. Fioranelli M, Piccoli M, Mileto GM, et al. Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 1999; 22: 743–749.[CrossRef][Medline] [Order article via Infotrieve]

11. Hnatkova K, Waktare JEP, Sopher SM, et al. A relationship between fluctuations in heart rate and the duration of subsequent episodes of atrial fibrillation. Pacing Clin Electrophysiol. 1998; 21: 181–185.[CrossRef][Medline] [Order article via Infotrieve]

12. Zimmermann M, Kalusche D. Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins. J Cardiovasc Electrophysiol. 2001; 12: 285–291.[CrossRef][Medline] [Order article via Infotrieve]

13. Dimmer C, Tavernier R, Gjorgov N, et al. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 1998; 82: 22–25.[Medline] [Order article via Infotrieve]

14. Wen ZC, Chen SA, Tai CT, et al. Role of autonomic tone in facilitating spontaneous onset of typical atrial flutter. J Am Coll Cardiol. 1998; 31: 602–607.[Abstract/Free Full Text]

15. Coccagna G, Capucci A, Bauleo S, et al. Paroxysmal atrial fibrillation in sleep. Sleep. 1997; 20: 396–398.[Medline] [Order article via Infotrieve]

16. Klingenheben T, Grönefeld G, Li YG, et al. Heart rate variability to assess changes in cardiac vagal modulation before the onset of paroxysmal atrial fibrillation in patients with and without structural heart disease. Ann Noninvas Electrocardiol. 1999; 4: 19–26.

17. Herweg B, Dalal P, Nagy B, et al. Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am J Cardiol. 1998; 82: 869–874.[CrossRef][Medline] [Order article via Infotrieve]

18. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996; 93: 1043–1065.[Free Full Text]

19. Chen YJ, Chen SA, Tai CT, et al. Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation. J Am Coll Cardiol. 1998; 32: 732–738.[Abstract/Free Full Text]

20. Lok NS, Lau CP. Abnormal vasovagal reaction, autonomic function, and heart rate variability in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 1998; 21: 386–395.[CrossRef][Medline] [Order article via Infotrieve]

21. Coumel P. Autonomic influences in atrial arrhythmias. J Cardiovasc Electrophysiol. 1996; 7: 999–1007.[Medline] [Order article via Infotrieve]

22. Huang JL, Wen ZC, Lee WL, et al. Changes in autonomic tone before the onset of paroxysmal atrial fibrillation. Int J Cardiol. 1998; 66: 275–283.[CrossRef][Medline] [Order article via Infotrieve]

23. Smeets JLRM, Allessie MA, Lammers WJEP, et al. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium: the role of the heart rate, autonomic transmitters, temperature, and potassium. Circ Res. 1986; 58: 96–108.[Abstract/Free Full Text]

24. Ninomyia I. Direct evidence of nonuniform distribution of vagal effects on dog atria. Circ Res. 1966; 19: 576–583.[Abstract/Free Full Text]

25. Wang Z, Pagé P, Nattel S. Mechanism of flecainide’s antiarrhythmic action in experimental atrial fibrillation. Circ Res. 1992; 71: 271–287.[Abstract/Free Full Text]

26. Schauerte P, Scherlag BJ, Pitha J, et al. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation. 2000; 102: 2774–2780.[Abstract/Free Full Text]

27. Tai CT, Chiou CW, Wen ZC, et al. Effect of phenylephrine on focal atrial fibrillation originating in the pulmonary veins and superior vena cava. J Am Coll Cardiol. 2000; 36: 788–793.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
EuropaceHome page
T. Yamada, N. Yoshida, Y. Murakami, T. Okada, Y. Yoshida, M. Muto, Y. Inden, and T. Murohara
The difference in autonomic denervation and its effect on atrial fibrillation recurrence between the standard segmental and circumferential pulmonary vein isolation techniques
Europace, October 29, 2009; (2009) eup330v1.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. A. Nichols, K. Reinier, and S. S. Chugh
Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation
Diabetes Care, October 1, 2009; 32(10): 1851 - 1856.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
R. L. Verrier and M. E. Josephson
Impact of Sleep on Arrhythmogenesis
Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 450 - 459.
[Full Text] [PDF]


Home page
CirculationHome page
E. J. Benjamin, P.-S. Chen, D. E. Bild, A. M. Mascette, C. M. Albert, A. Alonso, H. Calkins, S. J. Connolly, A. B. Curtis, D. Darbar, et al.
Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop
Circulation, February 3, 2009; 119(4): 606 - 618.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
P. M. Okin, K. Wachtell, S. E. Kjeldsen, S. Julius, L. H. Lindholm, B. Dahlof, D. A. Hille, M. S. Nieminen, J. M. Edelman, and R. B. Devereux
Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients: The LIFE Study
Circ Arrhythm Electrophysiol, December 1, 2008; 1(5): 337 - 343.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Doll, P. Pritzwald-Stegmann, M. Czesla, J. Kempfert, M. A. Stenzel, M. A. Borger, and F.-W. Mohr
Ablation of Ganglionic Plexi During Combined Surgery for Atrial Fibrillation
Ann. Thorac. Surg., November 1, 2008; 86(5): 1659 - 1663.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Y. Tan, S. Zhou, M. Ogawa, J. Song, M. Chu, H. Li, M. C. Fishbein, S.-F. Lin, L. S. Chen, and P.-S. Chen
Neural Mechanisms of Paroxysmal Atrial Fibrillation and Paroxysmal Atrial Tachycardia in Ambulatory Canines
Circulation, August 26, 2008; 118(9): 916 - 925.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Onorati, A. Curcio, G. Santarpino, D. Torella, P. Mastroroberto, L. Tucci, C. Indolfi, and A. Renzulli
Routine ganglionic plexi ablation during Maze procedure improves hospital and early follow-up results of mitral surgery.
J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 408 - 418.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Duprez
Cardiac Autonomic Imbalance in Pre-Hypertension and in a Family History of Hypertension
J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1902 - 1903.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C. B. de Vos, R. Nieuwlaat, H. J.G.M. Crijns, A. J. Camm, J.-Y. LeHeuzey, C. J. Kirchhof, A. Capucci, G. Breithardt, P. E. Vardas, R. Pisters, et al.
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey
Eur. Heart J., March 1, 2008; 29(5): 632 - 639.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J.-F. Sarrazin, G. Comeau, P. Daleau, J. Kingma, I. Plante, D. Fournier, and F. Molin
Reduced Incidence of Vagally Induced Atrial Fibrillation and Expression Levels of Connexins by n-3 Polyunsaturated Fatty Acids in Dogs
J. Am. Coll. Cardiol., October 9, 2007; 50(15): 1505 - 1512.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. C. Ziegelstein
Acute Emotional Stress and Cardiac Arrhythmias
JAMA, July 18, 2007; 298(3): 324 - 329.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Hou, B. J. Scherlag, J. Lin, Y. Zhang, Z. Lu, K. Truong, E. Patterson, R. Lazzara, W. M. Jackman, and S. S. Po
Ganglionated Plexi Modulate Extrinsic Cardiac Autonomic Nerve Input: Effects on Sinus Rate, Atrioventricular Conduction, Refractoriness, and Inducibility of Atrial Fibrillation
J. Am. Coll. Cardiol., July 3, 2007; 50(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al.
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
Europace, June 1, 2007; 9(6): 335 - 379.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Hirose and K. R. Laurita
Calcium-mediated triggered activity is an underlying cellular mechanism of ectopy originating from the pulmonary vein in dogs
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1861 - H1867.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Bollmann, D. Husser, L. Mainardi, F. Lombardi, P. Langley, A. Murray, J. J. Rieta, J. Millet, S. B. Olsson, M. Stridh, et al.
Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications.
Europace, November 1, 2006; 8(11): 911 - 926.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
CirculationHome page
M. Scanavacca, C. F. Pisani, D. Hachul, S. Lara, C. Hardy, F. Darrieux, I. Trombetta, C. E. Negrao, and E. Sosa
Selective Atrial Vagal Denervation Guided by Evoked Vagal Reflex to Treat Patients With Paroxysmal Atrial Fibrillation
Circulation, August 29, 2006; 114(9): 876 - 885.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
EuropaceHome page
P. Azzolini, G. Critelli, V. De Giorgi, G. B. Del Giudice, G. Ibba, D. Melissano, A. Scaccia, and A. Puglisi
Atrial tachyarrhythmia burden modelling by some electrophysiological parameters in pacemaker-recipient patients with Brady-Tachy syndrome
Europace, July 1, 2006; 8(7): 474 - 481.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Mehra, E. J. Benjamin, E. Shahar, D. J. Gottlieb, R. Nawabit, H. L. Kirchner, J. Sahadevan, and S. Redline
Association of Nocturnal Arrhythmias with Sleep-disordered Breathing: The Sleep Heart Health Study
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 910 - 916.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Vincenti, R. Brambilla, M. G. Fumagalli, R. Merola, and S. Pedretti
Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring.
Europace, March 1, 2006; 8(3): 204 - 210.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Takahashi, P. Jais, M. Hocini, P. Sanders, M. Rotter, T. Rostock, L.-F. Hsu, F. Sacher, J. Clementy, and M. Haissaguerre
Shortening of Fibrillatory Cycle Length in the Pulmonary Vein During Vagal Excitation
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 774 - 780.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Alex and L. Guvendik
Evaluation of Ventral Cardiac Denervation As a Prophylaxis Against Atrial Fibrillation After Coronary Artery Bypass Grafting
Ann. Thorac. Surg., February 1, 2005; 79(2): 517 - 520.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Vikman, K. Lindgren, T. H. Makikallio, S. Yli-Mayry, K.E. J. Airaksinen, and H. V. Huikuri
Heart rate turbulence after atrial premature beats before spontaneous onset of atrial fibrillation
J. Am. Coll. Cardiol., January 18, 2005; 45(2): 278 - 284.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Shelton
The AFFIRM study: Approaches to control rate in atrial fibrillation
J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2418 - 2418.
[Full Text] [PDF]


Home page
Eur Heart JHome page
F. Lombardi, D. Tarricone, F. Tundo, F. Colombo, S. Belletti, and C. Fiorentini
Autonomic nervous system and paroxysmal atrial fibrillation: a study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation
Eur. Heart J., July 2, 2004; 25(14): 1242 - 1248.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
O. F. Sharifov, V. V. Fedorov, G. G. Beloshapko, A. V. Glukhov, A. V. Yushmanova, and L. V. Rosenshtraukh
Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 483 - 490.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Puglisi, G. Altamura, F. Capestro, B. Castaldi, G. Critelli, S. Favale, L. Pavia, and G. Pettinati
Impact of Closed-Loop Stimulation, overdrive pacing, DDDR pacing mode on atrial tachyarrhythmia burden in Brady-Tachy Syndrome: A randomized study
Eur. Heart J., November 1, 2003; 24(21): 1952 - 1961.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Amar, H. Zhang, S. Miodownik, and A. H. Kadish
Competing autonomic mechanisms precedethe onset of postoperative atrial fibrillation
J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1262 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. H. Maisel
Autonomic modulation preceding the onset of atrial fibrillation
J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1269 - 1270.
[Full Text] [PDF]


Home page
HeartHome page
V. Markides and R. J Schilling
Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment
Heart, August 1, 2003; 89(8): 939 - 943.
[Full Text] [PDF]


Home page
CirculationHome page
H. Bonnemeier, U. K.H. Wiegand, M. Bettoni, and M. Zimmermann
Autonomic Tone Variations Before the Onset of Paroxysmal Atrial Fibrillation * Response
Circulation, February 11, 2003; 107 (5): e41 - e41.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/23/2753    most recent
01.CIR.0000018443.44005.D8v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bettoni, M.
Right arrow Articles by Zimmermann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bettoni, M.
Right arrow Articles by Zimmermann, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation
Related Collections
Right arrow Electrocardiology
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Autonomic, reflex, and neurohumoral control of circulation